Navigation Links
Vagal Nerve Stimulation Works To Treat Severe Depression

Psychiatrists day old reports about vagal nerve stimulation, a new therapy for treatment-resistant depression starts to benefit patients, confirmed// by a new preliminary brain scan research. Saint Louis University researchers reported it takes about 3 to 12 months to make vagal nerve stimulation in brain.

Saint Louis University, working in collaboration with Washington University School of Medicine, conducted a pilot study of brain scans of a small group of depressed patients who received vagal nerve stimulation after failing other therapies.

Positron emission tomography (PET) scans showed significant changes in brain activity starting three months after vagal nerve stimulation treatment began. These changes continued to evolve over the course of the next 21 months.

These changes in brain scans appear to ‘roughly parallel’ the significantly delayed effects that psychiatrists observed in improvement in mood.

‘The effects come after a significant period of treatment time,’ said Charles Conway, M.D., an assistant professor of psychiatry at Saint Louis University School of Medicine and the lead investigator of a vagal nerve stimulation research project conducted between 2000 and 2004.

Psychiatrists are not used to such a long time lag before a treatment begins to be effective, he added.

‘This is very different from the delays we see with existing treatments for depression, including pharmacotherapy and electroconvulsive therapy (ECT),’ Dr. Conway said. ‘The biggest changes in the brain that we're noting occur between 12 and 24 months after patients began receiving vagal nerve stimulation. In psychiatry, we're used to seeing results after six to 12 weeks.’

Dr. Conway cautioned the findings are preliminary and need replication.

‘But they suggest that in this type of therapy, the brain takes a relatively long time to change, perhaps as long as a year or more. In this sense, vagal nerve st imulation may represent a paradigm shift in the way we view depression treatment. Patients may have to be instructed to 'be patient,' with the expectations that the antidepressant effects will be slow to come.’

The good news, however, seems to be that those who benefit from the treatment stay better.

‘The existing evidence suggests that about 70 percent of patients who get better from vagal nerve stimulation at one year, stay better at two years,’ Dr. Conway said. ‘That is unheard of in a depressed population this severe, and suggests that the brain changes induced by this treatment appear to be long-lasting.’

Dr. Conway examined the brain scans of patients at three, six, 12 and 24 months intervals after they began receiving vagal nerve stimulation. Eight patients participated in the study for the three and six month scans, six patients at 12 months and four patients at 24 months. The size of the study group grew smaller during the two year investigation.

‘This is admittedly a very tiny population and the findings of this study are very preliminary. We need to do more research with a larger group of patients,’ Dr. Conway said. ‘That said, I think the findings are real and promising and beg more research.’

Vagal nerve stimulation was approved in 2005 by the U.S. Food and Drug Administration to treat severe treatment-resistant depression. A vagal nerve stimulator is similar to a cardiac pacemaker and is implanted in the chest with leads that run under the skin to the vagal nerve in the neck. The device emits electrical pulses to simulate the brain, and also is used to treat epilepsy.

Doctors don't know exactly why vagal nerve therapy works, but Dr. Conway says his new research gives some clues.

When Dr. Conway examined the neuroimages of four patients 24 months after they began receiving vagal nerve stimulation, he found brain activity that was similar to what doctors see in patients who have r eceived ECT.

‘There actually appears to be decreased activity in regions of the prefrontal cortex, which is very much parallel to the findings of treatment response in ECT, and the opposite of findings seen in medication-response to depression.’

He found unexpected action in the prefrontal cortex of the brain that is similar to brain activity in depressed patients immediately after they have received ECT and before its effect wears off.

‘No one knows exactly how vagal nerve stimulation works. This suggests that one way in which it works may parallel ECT,’ Dr. Conway said.

‘ECT had been considered to be the best therapy for treatment-resistant depression, but unfortunately the effects are not long-lasting. The data so far shows that one-third of the depressed patients who are treatment resistant are responsive to vagal nerve simulations and those who respond stay well.’

Source: Eurekalert
'"/>




Related medicine news :

1. Epilepsy Drug Helps Diabetic Nerve Damage
2. World’s First Nerve Stem Cells Produced
3. Children With Epilepsy Can Be Treated With Nerve Stimulation
4. FDA Approved Nerve-Stimulation Therapy Now Available In New York
5. Doctors Finish Mother-To-Son Nerve Surgery
6. Stem Cells From Hair Follicle To Repair Nerve Damage
7. Nerve regeneration for Spinal cord injuries
8. Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses
9. Dividing Nerve Cells Could Trigger Alzheimers Disease
10. Protein Found to Be Essential For Maintaining Nerve Health
11. Nerve Stimulator for Depression Though Not Effective Was Given Approval
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... firsts,: , TwinLink™ - the first dual ...
Breaking Medicine Technology: